Eyal Robenshtok
Overview
Explore the profile of Eyal Robenshtok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moskovitz A, Tsur N, Kaminer K, Dudkiewicz D, Robenshtok E
Head Neck
. 2025 Feb;
PMID: 40018788
Background: There is limited data on the recurrence risk following lobectomy in patients with microscopic extrathyroidal extension (mETE) and the significance of the site of mETE. Methods: A retrospective study...
2.
Robenshtok E, Bachar G, Ritter A
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39745824
Thyroid lobectomy has gained increasing popularity over the past decade as a treatment for differentiated thyroid cancer (DTC), largely due to a rise in the diagnosis of low-risk cancers and...
3.
Ayalon-Dangur I, Magid-Ohayon E, Shimon I, Robenshtok E
Endocr Pract
. 2024 Nov;
31(2):180-187.
PMID: 39581263
Objective: Iodinated contrast media (ICMs) are widely used in a variety of examinations and procedures. The aim of the current study was to investigate the efficacy of methimazole (MMI) in...
4.
5.
Papini E, Attanasio R, Zarkovic M, Nagy E, Negro R, Perros P, et al.
Endocrine
. 2024 Aug;
87(1):262-272.
PMID: 39217207
Background: Treatment of simple goiter (SG) growing over time with thyroid hormone (TH) therapy is discouraged by international guidelines. Purpose: To ascertain views of European thyroid specialists about TH treatment...
6.
Negro R, Zarkovic M, Attanasio R, Hegedus L, Nagy E, Papini E, et al.
Clin Endocrinol (Oxf)
. 2024 Jun;
101(2):180-190.
PMID: 38856700
Objectives: The use of levothyroxine (LT4) treatment aiming to improve fertility in euthyroid women with positive thyroid peroxidase antibodies (TPOAb) is not supported by the available evidence. The aim of...
7.
Duskin-Bitan H, Robenshtok E, Peretz A, Beckenstein T, Tsur N, Netzer D, et al.
Endocr Pract
. 2024 May;
30(8):731-736.
PMID: 38729568
Objective: COVID-19 infection and immunizations have been implicated in developing a range of thyroid diseases, including subacute thyroiditis (SAT). This study aimed to evaluate the association between COVID-19 infection and/or...
8.
Attanasio R, Zarkovic M, Papini E, Nagy E, Negro R, Perros P, et al.
Thyroid
. 2024 Feb;
34(4):429-441.
PMID: 38368541
Hypothyroidism is common, however, aspects of its treatment remain controversial. Our survey aimed at documenting treatment choices of European thyroid specialists and exploring how patients' persistent symptoms, clinician demographics, and...
9.
Ayalon-Dangur I, Turjeman A, Hirsch D, Robenshtok E, Tsvetov G, Gorshtein A, et al.
Pituitary
. 2023 Dec;
27(1):52-60.
PMID: 38064148
Purpose: The treatment strategy of non-functioning pituitary adenomas (NFPAs) includes surgery, radiotherapy, medical therapy, or observation without intervention. Cabergoline, a dopaminergic agonist, was suggested for the treatment of NFPA remnants...
10.
Zarkovic M, Attanasio R, Nagy E, Negro R, Papini E, Perros P, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1225202.
PMID: 38027187
Introduction: Thyroid specialists influence how hypothyroid patients are treated, including patients managed in primary care. Given that physician characteristics influence patient care, this study aimed to explore thyroid specialist profiles...